PHYSIOLOGICALLY-ACTIVE PEPTIDE DERIVATIVE FOR TREATMENT OF EYE DISEASES, PHARMACEUTICAL COMPOSITION, NASAL/NASAL DROP PREPARATION, AND USE OF PHYSIOLOGICALLY-ACTIVE PEPTIDE DERIVATIVE

Title:

PHYSIOLOGICALLY-ACTIVE PEPTIDE DERIVATIVE FOR TREATMENT OF EYE DISEASES, PHARMACEUTICAL COMPOSITION, NASAL/NASAL DROP PREPARATION, AND USE OF PHYSIOLOGICALLY-ACTIVE PEPTIDE DERIVATIVE

Document Type and Number:

WIPO Patent Application WO/2024/101434

Kind Code:

A1

Abstract:

This physiologically-active peptide derivative for the treatment of eye diseases comprises a physiologically-active peptide sequence and a functional sequence comprising a membrane permeation-promoting sequence and an endosomal escape-promoting sequence.

More Like This:

WO/2002/066650	STREPTOCOCCUS PYOGENES POLYPEPTIDES AND CORRESPONDING DNA FRAGMENTS
WO/2016/175551	IMMUNE CONJUGATE HAVING DENDRON CONJUGATED TO ANTIBODY AND USE THEREOF
JP2024007408	Staining method, liquid composition for staining, and kit for staining

Inventors:

YAMASHITA CHIKAMASA (JP)

Application Number:

PCT/JP2023/040455

Publication Date:

May 16, 2024

Filing Date:

November 09, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV TOKYO SCIENCE FOUND (JP)

International Classes:

C07K19/00; A61K38/16; A61K47/64; A61P27/02; C07K14/47; A61K38/26; C07K14/605

Domestic Patent References:

WO2016035820A1	2016-03-10
WO2014164670A1	2014-10-09
WO2009153960A1	2009-12-23
WO2022140118A1	2022-06-30
WO2022087669A1	2022-05-05
WO2022239839A1	2022-11-17

Attorney, Agent or Firm:

TAIYO, NAKAJIMA & KATO (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: GLYCOSYLATED NEUROPEPTIDE DERIVATIVE INCLUDING NEUROPEPTIDE SEQUENCE AND SUGAR CHAIN, PHARMACEUTICAL...

Next Patent: TUBE UNIT, DEAERATION MODULE, AND METHOD FOR PRODUCING TUBE UNIT